Bay Street News, June, 2020

IFX-1 treatment showed a trend in lower 28-day all-cause mortality rate, along with trends of maintained kidney function, faster normalization […]

SOUTH SAN FRANCISCO, Calif., June 17, 2020 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing […]

LEXINGTON, Mass., June 17, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, […]

**Not for distribution to United States Newswire Services or release publication, distribution or dissemination, directly or indirectly, in the United […]

OTTAWA, June 17, 2020 (GLOBE NEWSWIRE) — HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced that […]

OTTAWA, 17 juin 2020 (GLOBE NEWSWIRE) — HEXO Corp (« HEXO », ou la « Société ») (TSX : HEXO ; NYSE : HEXO) […]

NEW YORK, June 17, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), an emerging […]

Phase 2 study results demonstrated the potential clinical benefit of exebacase, when used in addition to existing antibiotics, for the […]

NEW YORK and CLEVELAND, June 17, 2020 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene […]

– Preclinical CLS-AX data demonstrates a potentially long-acting therapy for neovascular age-related macular degeneration –– Evidence supports the reliability, repeatability, […]